SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $309,000 | -90.9% | 13,009 | -86.6% | 0.01% | -87.8% |
Q1 2019 | $3,407,000 | +121.1% | 97,242 | +109.7% | 0.07% | +85.0% |
Q4 2018 | $1,541,000 | +20.1% | 46,376 | +65.5% | 0.04% | +48.1% |
Q1 2018 | $1,283,000 | -39.3% | 28,015 | -46.6% | 0.03% | -41.3% |
Q4 2017 | $2,115,000 | +123.3% | 52,461 | +120.8% | 0.05% | +155.6% |
Q3 2017 | $947,000 | -55.7% | 23,758 | -65.2% | 0.02% | -65.4% |
Q1 2017 | $2,137,000 | +170.8% | 68,285 | +118.6% | 0.05% | +85.7% |
Q4 2016 | $789,000 | -75.4% | 31,244 | -75.9% | 0.03% | -71.7% |
Q3 2016 | $3,211,000 | -43.4% | 129,825 | -53.4% | 0.10% | -47.1% |
Q2 2016 | $5,676,000 | +8.9% | 278,668 | -18.4% | 0.19% | +25.5% |
Q1 2016 | $5,210,000 | -2.6% | 341,626 | -12.6% | 0.15% | +18.3% |
Q4 2015 | $5,351,000 | +35.7% | 390,994 | +39.2% | 0.13% | +1.6% |
Q3 2015 | $3,942,000 | -67.4% | 280,966 | -60.5% | 0.12% | -62.1% |
Q2 2015 | $12,075,000 | +1269.0% | 711,129 | +875.0% | 0.33% | +1386.4% |
Q1 2015 | $882,000 | – | 72,939 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |